IMSCO INC /MA/
8-K, 1999-02-19
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: AMERICAN TECHNOLOGY CORP /DE/, DEF 14A, 1999-02-19
Next: TRANSMEDIA ASIA PACIFIC INC, 10-Q, 1999-02-19




                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549


                                    FORM 8-K


                 Current Report Pursuant to Section 13 or 15(d)
                     of the Securities Exchange Act of 1934


        Date of Report (Date of earliest event reported) February 9, 1999

                             IMSCO Technologies Inc.
             (Exact name of registrant as specified in its charter)


        Delaware                        0-24520                  04-3021770
(State or other jurisdiction         (Commission                (IRS Employer
    of incorporation)                File Number)            Identification No.)


40 Bayfield Drive, North Andover, Massachusetts                     01845
(Address of principal executive offices)                         (Zip Code)

Registrant's telephone number, including area code (978) 689-2080




- --------------------------------------------------------------------------------
        (Former name or former address, if changed since last report)



<PAGE>


Item 5. Other Events

     On February 9, 1999, IMSCO Technologies,  Inc. (the "Company")  completed a
private offering of $600,000 of Convertible Debentures due January 31, 2002 (the
"Debentures")  and 120,000 Common Stock Purchase  Warrants  exercisable at $1.50
per share for a period ending January 31, 2002 (the "Warrants").  The Debentures
and Warrants were issued and sold to one investor in accordance  with Securities
and  Exchange  Commission  Regulation D and have not been  registered  under the
Securities  Act of 1933,  as  amended  (the  "Securities  Act"),  and may not be
offered or sold in the United States absent  registration  under the  Securities
Act or an applicable exemption from the registration requirements thereof.

     The Debentures are unsecured  obligations of the Company and will mature on
January 31, 2002.  Interest on the  Debentures  is payable  quarter-annually  on
February 1, May 1, August and  November 1 of each year,  commencing  May 1,1999.
Interest at the  Company's  option may be paid in cash or in common stock of the
Company.  The investor may convert the Debentures into shares of common stock at
a price  equal to the lesser of (i) 75% of the Market  Price (as  defined in the
Purchase  Agreement  below) on the  conversion  notice  date,  or (ii) $1.00 per
share;  provided  that  the  investor  shall  not  acquire  10% or  more  of the
outstanding  shares  of  common  stock of the  Company,  through  conversion  or
otherwise, except in the event of a tender offer or merger or acquisition of the
Company.

     The Warrants permit the holder to acquire 120,000 shares of Common Stock at
an exercise  price of $1.50 per share for a period ending  January 31, 2002. The
Warrants  contain  certain  standard  anti-dilution  provisions.  The Holder has
certain  demand  registration  rights and  piggy-back  registration  rights with
respect to the Common  Stock  issuable  upon  exercise of the  Warrants  and the
Common Stock issuable upon conversion of the Debentures.

     The net proceeds of the offering,  after deducting  underwriting  discounts
and  commissions  and  expenses  payable  by  the  Company,  were  approximately
$522,000.  The Company  expects to use the net proceeds of the offering to repay
certain  indebtedness  of the  Company  and  for  working  capital  and  general
corporate purposes.

Item 7. Financial Statements, Pro Forma Financial Information and Exhibits

     (c)  Exhibits

   Exhibit
    Number              Exhibit Name
    ------              ------------
     4.1   Form of 8% Convertible debenture Due 2002


     10.1  Debenture and Warrant Purchase Agreement dated as of February 3, 1999


<PAGE>


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Dated: February 19, 1999         IMSCO TECHNOLOGIES, INC.


                                 By: /s/  Alexander T. Hoffmann
                                     ------------------------------------
                                     Alexander T. Hoffmann
                                     Chairman and Chief Executive Officer


<PAGE>


                                  EXHIBIT INDEX



   Exhibit
    Number                  Exhibit Name
    ------                  ------------
     4.1   Form of 8% Convertible debenture Due 2002


     10.1  Debenture and Warrant Purchase Agreement dated as of February 3, 1999




EXHIBIT 4.1


                       8% CONVERTIBLE DEBENTURE

     NEITHER  THESE  SECURITIES  NOR  THE  SECURITIES   ISSUABLE  UPON
     CONVERSION  HEREOF HAVE BEEN  REGISTERED  WITH THE UNITED  STATES
     SECURITIES AND EXCHANGE  COMMISSION OR THE SECURITIES  COMMISSION
     OF ANY STATE  PURSUANT TO AN EXEMPTION  FROM  REGISTRATION  UNDER
     REGULATION D  PROMULGATED  UNDER THE  SECURITIES  ACT OF 1933, AS
     AMENDED (THE "ACT"). THE SECURITIES ARE RESTRICTED AND MAY NOT BE
     OFFERED,  SOLD,  PLEDGED,   TRANSFERRED  OR  ASSIGNED  EXCEPT  AS
     PERMITTED  UNDER THE ACT  PURSUANT TO AN  EFFECTIVE  REGISTRATION
     STATEMENT OR AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS.


No.1                                                                US $ 600,000

                            IMSCO TECHNOLOGIES, INC.

                  8% CONVERTIBLE DEBENTURE DUE JANUARY 31, 2002


     THIS  DEBENTURE  is  issued  by IMSCO  TECHNOLOGIES,  INC.,  a  corporation
organized and existing  under the laws of the State of Delaware (the  "Company")
and is designated as its 8% Convertible Debenture Due January 31, 2002.

     FOR VALUE  RECEIVED,  the Company  promises  to pay to AMRO  INTERNATIONAL,
S.A.,  or permitted  assigns (the  "Holder"),  the  principal sum of Six Hundred
Thousand  and 00/100 (US  $600,000)  Dollars on January 31, 2002 (the  "Maturity
Date") and to pay interest on the  principal sum  outstanding  from time to time
quarterly  in  arrears  at the rate of 8% per  annum  accruing  from the date of
initial  issuance.  Accrual of interest shall commence on the first business day
to occur after the date of initial  issuance and continue  until payment in full
of the  principal sum has been made or duly  provided  for.  Quarterly  interest
payments  shall be due and  payable  on July 1,  October 1,  February  1, May 1,
August 1 and  November  1 of each  year,  commencing  with May 1, 1999 or upon a
conversion  of the  debenture  into  Common  Stock as  described  below . If any
interest payment date or the Maturity Date is not a business day in the State of
New York, then such payment shall be made on the next  succeeding  business day.
Subject to the  provisions of Paragraph 4 below,  the interest on this Debenture
is payable at the option of the Company, in cash or in shares of Common Stock of
the Company  ("Common Stock") valued at the Conversion Price (as defined herein)
on the interest  payment  date,  at the address last  appearing on the Debenture
Register  of the  Company as  designated  in writing by the Holder  from time to
time. The Company will pay the principal of and any accrued but unpaid  interest
due upon this Debenture on the Maturity Date,  less any amounts  required by law
to be deducted,  to the registered  holder of this Debenture as of the tenth day
prior to the  Maturity  Date and  addressed  to such holder at the last  address
appearing on the Debenture  Register.  The forwarding of the required  number of
shares of Common  Stock  determined  pursuant to the  provisions  of Paragraph 4
below, shall constitute a payment of principal and interest


<PAGE>


hereunder  and shall  satisfy and  discharge  the  liability  for  principal and
interest  on  this  Debenture  to the  extent  of  the  sum  represented  by the
equivalent  Conversion Price value of such shares of Common Stock (as defined in
Paragraph 3 below) plus any amounts so deducted.

     This Debenture is subject to the following additional provisions:

     1. The Company shall be entitled to withhold from all payments of principal
of, and interest on, this  Debenture any amounts  required to be withheld  under
the  applicable  provisions  of the  United  States  income  tax  laws or  other
applicable  laws at the time of such  payments,  and Holder  shall  execute  and
deliver all required documentation in connection therewith.

     2. This Debenture has been issued subject to investment  representations of
the  original  purchaser  hereof and may be  transferred  or  exchanged  only in
compliance  with the Securities  Act of 1933, as amended (the "Act"),  and other
applicable  state and  foreign  securities  laws.  In the event of any  proposed
transfer of this Debenture,  the Company may require, prior to issuance of a new
Debenture in the name of such other person,  that it receive reasonable transfer
documentation  including a legal  opinion that the issuance of the  Debenture in
such  other  name  does  not and will not  cause a  violation  of the Act or any
applicable  state securities laws. Prior to due presentment for transfer of this
Debenture,  the  Company  and any agent of the  Company  may treat the person in
whose name this Debenture is duly registered on the Company's Debenture Register
as the owner hereof for the purpose of receiving  payment as herein provided and
for all other  purposes,  whether or not this Debenture be overdue,  and neither
the Company nor any such agent shall be affected by notice to the contrary. This
Debenture has been executed and delivered  pursuant to the Debenture and Warrant
Purchase  Agreement  dated as of  February  3, 1999  between the Company and the
original  Holder  (the  "Purchase  Agreement"),  and is subject to the terms and
conditions of the Purchase Agreement, which are, by this reference, incorporated
herein and made a part hereof.  Capitalized terms used and not otherwise defined
herein  shall  have  the  meanings  set  forth  for such  terms in the  Purchase
Agreement.  Payments  under  the  Debenture  shall be made to the  Holder at the
address set forth I the Purchase Agreement.

     3. The Holder of this Debenture is entitled,  at its option,  to convert at
any time commencing on the date hereof,  the principal  amount of this Debenture
or any portion thereof, together with accrued but unpaid interest, provided that
the portion of the principal  amount so converted is Five  Thousand  Dollars (US
$5,000) or a multiple thereof (unless if at the time of such election to convert
the  aggregate  principal  amount of this  Debenture is less than Five  Thousand
Dollars (US $5,000),  then the whole amount thereof) into shares of Common Stock
of the Company  ("Conversion  Shares") at a  conversion  price for each share of
Common  Stock  ("Conversion  Price")  equal  to 75% of the  Market  Price at the
Conversion  Date (as  defined in Section 8  hereof),  but in no event  shall the
Conversion  Price be greater than $1.00 per share (adjusted for any Common Stock
dividend, split or reverse split effected after the date of this Debenture). The
term "Market Price" shall have the meaning set forth in the Purchase Agreement.

<PAGE>


     4. The entire unpaid balance of this Debenture and accrued interest thereon
outstanding on the Maturity Date hereof shall automatically  convert into Common
Stock at the Conversion Price on the Maturity Date (the "Mandatory Conversion").

     5.  Notwithstanding  the  provisions of the Debenture and Warrant  Purchase
Agreement or of the Warrants, in no event other than upon a Mandatory Conversion
or while there is outstanding a tender offer for any or all of the shares of the
Company's  common stock shall the holder be entitled,  or shall the Company have
the obligation, to convert all or any portion of this Debenture (and the Company
shall not have the right to pay interest on this  Debenture) to the extent that,
after  such  conversion,  the sum of (1) the  number of  shares of Common  Stock
beneficially owned by the Holder and its Affiliates (other than shares of Common
Stock  which may be deemed  beneficially  owned  through  the  ownership  of the
unconverted  portion of the Debentures or unexercised  portion of the Warrants),
and (2) the number of shares of Common Stock issuable upon the conversion of the
Debentures or exercise of the Warrants  with respect to which the  determination
of this  proviso is being made,  would  result in  beneficial  ownership  by the
Holder and its affiliates of more than 9.99% of the outstanding shares of Common
Stock (after taking into account the shares to be issued to the Holder upon such
conversion or exercise).  For purposes of the  immediately  preceding  sentence,
beneficial ownership shall be determined in accordance with Section 13(d) of the
Securities  Exchange  Act of 1934,  as amended  (the "1934 Act") and  Regulation
13D-G thereunder,  except as otherwise  provided in clause (1) of such sentence.
The Holder  further  agrees that if the Holder  transfers or assigns any of this
Debenture to a party who or which would not be  considered  an  Affiliate,  such
transfer or assignment  shall be made subject to the  transferee's or assignee's
specific  agreement  to be bound the  provisions  of this  paragraph  as if such
transferee or assignee were a signatory to this Agreement.

     6.  Notwithstanding  anything  to the  contrary  contained  herein,  if the
Company's  shares of Common  Stock  subsequently  become  listed on the New York
Stock Exchange,  the American Stock Exchange,  the NASDAQ National Market System
or the NASDAQ SmallCap  Market,  in the event that a conversion (when aggregated
with  all  prior  conversions  of  portions  of this  Debenture  and  any  other
Convertible  Debenture issued pursuant to the Agreement and all shares of Common
Stock  issuable  upon  exercise of the Warrants  (as defined in the  Agreement))
requires  the  Company to issue a number of shares of Common  Stock  which would
exceed 19.9% of the number of shares of Common Stock issued and  outstanding  on
the date of this  Debenture,  the Company shall issue only such number of shares
of Common  Stock as shall not exceed such limit and shall pay the Holder cash in
the  amount  of the  Market  Price for the  number of shares of Common  Stock in
excess of such  number of shares  into  which  this  Debenture  (or the  portion
thereof then being  converted)  is then  convertible  at the  Conversion  Price,
unless the Company has obtained  shareholder approval for such issuance pursuant
to the rules of the referenced  stock market,  or as otherwise  permitted by the
referenced stock market.

     7. Conversion  shall be effectuated by  surrendering  this Debenture to the
Company  (only  if such  Conversion  will  convert  all  outstanding  principal)
together with the form of conversion  notice  attached  hereto as Exhibit A (the


<PAGE>


"Notice of  Conversion"),  executed by the Holder of this  Debenture  evidencing
such  Holder's  intention to convert this  Debenture or a specified  portion (as
above provided) hereof.  The Notice of Conversion may be delivered or telecopied
to the Company, provided that the original Debenture is delivered to the Company
within seven (7) business days thereafter by express  courier.  Interest accrued
or accruing  from the date of issuance to the date of conversion  shall,  at the
option of the  Company,  be paid in cash as set forth  above or in Common  Stock
upon conversion at the Conversion Price on the Conversion Date. No fraction of a
share or scrip  representing a fraction of a share will be issued on conversion,
but the number of shares  issuable  shall be rounded  down to the nearest  whole
share. The date on which Notice of Conversion is given shall be deemed to be the
date on which the Holder faxes the Notice of Conversion  duly  executed,  to the
Company.  Facsimile  delivery of the conversion  notice shall be accepted by the
Company at facsimile number (718) 843-8504, Attn.: Chief Executive Officer.

The term "Conversion Date" means, with respect to any conversion  elected by the
holder  of the  Debenture,  the date  specified  in the  Notice  of  Conversion,
provided  the copy of the Notice of  Conversion  is  telecopied  to or otherwise
delivered to the Company in  accordance  with the  provisions  hereof so that is
received by the Company on or before such specified date.

The Company shall, at its expense,  take all actions and use all means necessary
and  diligent  to  cause  its  transfer   agent  to  deliver  the   certificates
representing  the Converted  Shares  issuable upon  conversion of any Debentures
(together  with  Debentures  not being so  converted)  to the Holder via express
courier,  by electronic  transfer or  otherwise,  within three (3) business days
(such third  business  day, the  "Delivery  Date") after (A) the business day on
which the Company has received both of the Notice of Conversion (by facsimile or
other delivery) and the original Debentures being converted (and if the same are
not  delivered  to the  Company on the same date,  the date of  delivery  of the
second of such  items) or (B) the date an  interest  payment on the  Debentures,
which the  Company  has  elected  to pay by the  issuance  of Common  Stock,  as
contemplated by the Debentures, was due.

The  Company  understands  that a delay in the  issuance of the Shares of Common
Stock beyond the Delivery Date could result in economic  loss to the Holder.  As
compensation  to the  Holder  for such  loss,  the  Company  agrees  to pay late
payments to the Holder for late issuance of Shares upon Conversion in accordance
with the following  schedule  (where "No.  Business Days Late" is defined as the
number of business days beyond two (2) business days from the Delivery Date):


                                      Late Payment For
                                      Each $10,000 Principal of
      No. Business Days Late          Debentures Being Converted
      ----------------------          --------------------------
             1                          $100
             2                          $200
             3                          $300
             4                          $400
             5                          $500
             6                          $600
             7                          $700
             8                          $800
             9                          $900
            10                          $1,000
           >10                          $1,000 + $200 for each Business Day Late
                                        beyond 10 days


<PAGE>


The Company shall pay any payments  incurred  under this Section in  immediately
available  funds upon demand.  Nothing  herein shall limit the Holder's right to
pursue actual damages for the Company's  failure to issue and deliver the Common
Stock to the Holder. Furthermore, in addition to any other remedies which may be
available to the Holder,  in the event that the Company  fails for any reason to
effect  delivery of such shares of Common  Stock  within two (2)  business  days
after the  Delivery  Date,  the Holder will be  entitled to revoke the  relevant
Notice  of  Conversion  by  delivering  a notice to such  effect to the  Company
whereupon the Company and the Holder shall each be restored to their  respective
positions immediately prior to delivery of such Notice of Conversion.

If, by the relevant  Delivery  Date, the Company fails for any reason to deliver
the Shares to be issued upon  conversion  of a Debenture and after such Delivery
Date,  the holder of the  Debentures  being  converted (a  "Converting  Holder")
purchases,  in an open market  transaction or otherwise,  shares of Common Stock
(the "Covering  Shares") in order to make delivery in  satisfaction of a sale of
Common Stock by the Converting  Holder (the "Sold Shares"),  which delivery such
Converting  Holder  anticipated  to make using the Shares to be issued upon such
conversion (a  "Buy-In"),  the Company shall pay to the  Converting  Holder,  in
addition  to  all  other  amounts   contemplated  in  other  provisions  of  the
Transaction  Agreements,  and not in lieu thereof,  the Buy-In Adjustment Amount
(as defined below).  The "Buy-In  Adjustment  Amount" is the amount equal to the
excess,  if any, of (x) the Converting  Holder's total purchase price (including
brokerage commissions, if any) for the Covering Shares over (y) the net proceeds
(after brokerage commissions, if any) received by the Converting Holder from the
sale of the Sold Shares.  The Company shall pay the Buy-In  Adjustment Amount to
the  Company in  immediately  available  funds  immediately  upon  demand by the
Converting  Holder.  By  way  of  illustration  and  not  in  limitation  of the
foregoing,  if the Converting  Holder  purchases shares of Common Stock having a
total purchase price  (including  brokerage  commissions)  of $11,000 to cover a
Buy-In  with  respect  to  shares of Common  Stock it sold for net  proceeds  of
$10,000,  the Buy-In  Adjustment Amount which Company will be required to pay to
the Converting Holder will be $1,000.

     8. No provision of this  Debenture  shall alter or impair the obligation of
the Company,  which is absolute and unconditional,  to pay the principal of, and
interest on, this  Debenture at the time,  place,  and rate,  and in the coin or
currency or shares of Common  Stock,  herein  prescribed.  This  Debenture  is a
direct obligation of the Company.

     9. No  recourse  shall be had for the payment of the  principal  of, or the
interest  on, this  Debenture,  or for any claim based  hereon,  or otherwise in
respect hereof,  against any  incorporator,  shareholder,  employee,  officer or
director,  as such,  past,  present or future,  of the Company or any  successor


<PAGE>


corporation,  whether by virtue of any constitution,  statute or rule of law, or
by the enforcement of any assessment or penalty or otherwise, all such liability
being, by the acceptance  hereof and as part of the  consideration for the issue
hereof, expressly waived and released.

     10. If the Company merges or consolidates with another corporation or sells
or transfers all or  substantially  all of its assets to another  person and the
holders  of the  Common  Stock are  entitled  to receive  stock,  securities  or
property in respect of or in exchange for Common  Stock,  then as a condition of
such  merger,  consolidation,  sale  or  transfer,  the  Company  and  any  such
successor,  purchaser or transferee  agree that the Debenture may  thereafter be
converted  on the terms and subject to the  conditions  set forth above into the
kind and amount of stock,  securities or property  receivable  upon such merger,
consolidation,  sale or  transfer  by a holder of the number of shares of Common
Stock into which this  Debenture  might have been converted  immediately  before
such merger, consolidation, sale or transfer, subject to adjustments which shall
be as nearly equivalent as may be practicable.

     11. This  Debenture  shall be governed by and construed in accordance  with
the  laws  of the  State  of New  York.  Each  of the  parties  consents  to the
jurisdiction  of the federal  courts whose  districts  encompass any part of the
City of New York or the state  courts of the  State of New York  sitting  in the
City of New York in connection with any dispute arising under this Agreement and
hereby waives, to the maximum extent permitted by law, any objection,  including
any  objection  based on  forum  non  conveniens,  to the  bringing  of any such
proceeding in such jurisdictions.

     12. The following shall constitute an "Event of Default":

          a.   The Company shall default in the payment of principal or interest
               on this  Debenture  and same shall  continue for a period of five
               (5) days; or

          b.   Any of the  representations  or  warranties  made by the  Company
               herein,  in  the  Purchase  Agreement,  the  Registration  Rights
               Agreement, or in any agreement, certificate or financial or other
               written  statements  heretofore  or  hereafter  furnished  by the
               Company in  connection  with the  execution  and delivery of this
               Debenture or the Purchase  Agreement shall be false or misleading
               in any material respect at the time made; or

          c.   The Company  fails to issue  shares of Common Stock to the Holder
               or to cause its  Transfer  Agent to issue  shares of Common Stock
               upon  exercise  by the  Holder  of the  conversion  rights of the
               Holder in accordance with the terms of this  Debenture,  fails to
               transfer  or  to  cause  its  Transfer   Agent  to  transfer  any
               certificate  for shares of Common Stock issued to the Holder upon
               conversion  of  this  Debenture  as and  when  required  by  this
               Debenture or the Registration Rights Agreement,


<PAGE>


               and such  transfer is  otherwise  lawful,  or fails to remove any
               restrictive legend or to cause its Transfer Agent to transfer any
               certificate  or any shares of Common  Stock  issued to the Holder
               upon  conversion  of this  Debenture as and when required by this
               Debenture,  the  Purchase  Agreement or the  Registration  Rights
               Agreement and such legend  removal is otherwise  lawful,  and any
               such failure shall  continue  uncured for five (5) business days;
               or

          d.   The  Company  shall fail to perform or observe,  in any  material
               respect,  any  other  covenant,   term,   provision,   condition,
               agreement  or  obligation  of  the  Company  under  the  Purchase
               Agreement,  the  Registration  Rights Agreement or this Debenture
               and such failure  shall  continue  uncured for a period of thirty
               (30) days after  written  notice from the Holder of such failure;
               or

          e.   The Company  shall (1) admit in writing its  inability to pay its
               debts  generally as they mature;  (2) make an assignment  for the
               benefit of creditors or commence proceedings for its dissolution;
               or (3) apply for or  consent  to the  appointment  of a  trustee,
               liquidator or receiver for its or for a  substantial  part of its
               property or business; or

          f.   A trustee,  liquidator  or receiver  shall be  appointed  for the
               Company or for a  substantial  part of its  property  or business
               without its consent and shall not be discharged within sixty (60)
               days after such appointment; or

          g.   Any governmental agency or any court of competent jurisdiction at
               the instance of any  governmental  agency shall assume custody or
               control of the whole or any substantial portion of the properties
               or assets of the Company and shall not be dismissed  within sixty
               (60) days thereafter; or

          h.   Any money  judgment,  writ or warrant of  attachment,  or similar
               process  in excess of One  Million  ($1,000,000)  Dollars  in the
               aggregate shall be entered or filed against the Company or any of
               its   properties  or  other  assets  and  shall  remain   unpaid,
               unvacated,  unbonded or unstayed  for a period of sixty (60) days
               (or such  later  period  for  payment  as any such  judgment  may
               specify)  or in any event  later  than five (5) days prior to the
               date of any proposed sale thereunder; or

          i.   Bankruptcy, reorganization, insolvency or liquidation proceedings
               or other  proceedings  for relief under any bankruptcy law or any
               law for the relief of debtors  shall be  instituted by or against
               the Company and, if


<PAGE>


               instituted  against the Company,  shall not be  dismissed  within
               sixty (60) days after such  institution  or the Company  shall by
               any action or answer  approve of, consent to, or acquiesce in any
               such proceedings or admit the material allegations of, or default
               in answering a petition filed in any such proceeding; or

          j.   The Company  shall have its Common  Stock  suspended  or delisted
               from trading on an exchange or the NASD OTC Bulletin Board market
               for in excess of two Trading Days;

Then, or at any time  thereafter,  and in each and every such case,  unless such
Event of Default  shall have been waived in writing by the Holder  (which waiver
shall not be deemed to be a waiver of any  subsequent  default) at the option of
the Holder and in the Holder's  sole  discretion,  the Holder may consider  this
Debenture immediately due and payable,  without presentment,  demand, protest or
notice of any kind, all of which are hereby expressly waived, anything herein or
in any note or other instruments contained to the contrary notwithstanding,  and
the  Holder  may  immediately  enforce  any and all of the  Holder's  rights and
remedies  provided  herein or any  other  rights or  remedies  afforded  by law;
provided,  that any payment of this  Debenture  in  connection  with an Event of
Default (other than a delisting of its Common Stock pursuant to clause (j.)) may
be made, at the  Company's  election,  in cash or in shares of Common Stock,  in
such number as would be issued at the Conversion Price on the date the Debenture
becomes due and  payable. 

13. Nothing  contained in this Debenture  shall be construed as conferring  upon
the Holder the right to vote or to  receive  dividends  or to consent or receive
notice as a shareholder in respect of any meeting of  shareholders or any rights
whatsoever as a shareholder of the Company,  unless and to the extent  converted
in accordance with the terms hereof.


     IN WITNESS  WHEREOF,  the  Company has caused  this  instrument  to be duly
executed by an officer thereunto duly authorized.


Dated:   February 4, 1999

                                       IMSCO TECHNOLOGIES, INC.



                                       By:   /s/Alexander T. Hoffmann
                                       -----------------------------------
                                       Chairman and Chief Executive Officer



<PAGE>


                                    EXHIBIT A

                              NOTICE OF CONVERSION*

   (To be Executed by the Registered Holder in order to Convert the Debenture)

                  The  undersigned   hereby  irrevocably  elects  to  convert  $
________________  of the  principal  amount of the above  Debenture No. ___ into
Shares of Common Stock of IMSCO TECHNOLOGIES,  INC. (the "Company") according to
the conditions hereof, as of the date written below.


Date of Conversion ____________________________________________________________


Applicable Conversion Price  ___________________________________________________


Accrued Interest through Date of Conversion $__________________.

Number of Shares to be Issued: ___________________


Signature_____________________________________________________________________
                                  [Name]

Address:______________________________________________________________________

        ______________________________________________________________________


* This Notice of  Conversion  must be received by the Company via  facsimile  in
order to effectuate the conversion,  with the original Debenture being delivered
to the Company within seven business days thereafter by express courier.



EXHIBIT 10.1


                    DEBENTURE AND WARRANT PURCHASE AGREEMENT

                                     Between

                            IMSCO Technologies, Inc.

                                       and

                         the Investors signatory hereto


     DEBENTURE AND WARRANT PURCHASE  AGREEMENT dated as of February 3, 1999 (the
"Agreement"),  between the investor or investors set forth on the signature page
hereto  (each  an   "Investor"   and  together  the   "Investors"),   and  IMSCO
Technologies,  Inc., a corporation  organized and existing under the laws of the
State of Delaware (the "Company").

     WHEREAS,  the  parties  desire  that,  upon the  terms and  subject  to the
conditions  contained herein, the Company shall issue and sell to the Investors,
and the Investors  shall purchase  pro-rata,  as set forth on the signature page
hereof,  (i) $600,000  principal  amount of  Convertible  Debentures (as defined
below) and (ii) Warrants (as defined  below) to purchase up to 120,000 shares of
the Common Stock (as defined below).

     WHEREAS,  such  investments will be made in reliance upon the provisions of
Section 4(2)  ("Section  4(2)") of the United States  Securities Act of 1933, as
amended,  and Regulation D ("Regulation  D") and the other rules and regulations
promulgated  thereunder (the "Securities Act"), and/or upon such other exemption
from the  registration  requirements  of the  Securities Act as may be available
with  respect  to any or all of the  investments  in the  securities  to be made
hereunder.

     NOW, THEREFORE, the parties hereto agree as follows:

                                   ARTICLE I

                               Certain Definitions

Section 1.1.  "Capital Shares" shall mean the Common Stock and any shares of any
other class of common  stock  whether now or  hereafter  authorized,  having the
right to participate in the distribution of earnings and assets of the Company.

Section 1.2. "Capital Shares Equivalents" shall mean any securities,  rights, or
obligations  that are convertible  into or exchangeable for or give any right to
subscribe  for any  Capital  Shares of the Company or any  warrants,  options or
other rights to subscribe for or purchase Capital Shares or any such convertible
or exchangeable securities.

Section  1.3.  "Closing"  shall mean the closing of the purchase and sale of the
Convertible Debenture and Warrants pursuant to Section 2.1.

Section 1.4.  "Closing  Date" shall mean the date on which all conditions to the
Closing  have been  satisfied  (as  defined in Section  2.1 (a)  hereto) and the
Closing shall have occurred.


                                       1
<PAGE>


Section 1.5.  "Common Stock" shall mean the Company's common stock, no par value
per share.

Section 1.6.  "Conversion Shares" shall mean the shares of Common Stock issuable
upon conversion of the Convertible Debenture.

Section  1.7.  "Convertible  Debenture(s)"  shall  mean the  $600,000  aggregate
principal amount of Convertible Debentures in the form of Exhibit A hereto to be
issued to the Investors pursuant to this Agreement.

Section 1.8. "Damages" shall mean any loss, claim,  damage,  judgment,  penalty,
deficiency,  liability,  costs  and  expenses  (including,  without  limitation,
reasonable  attorney's fees and  disbursements and reasonable costs and expenses
of expert witnesses and investigation).

Section  1.9.  "Effective  Date"  shall  mean the date on  which  the SEC  first
declares  effective  a  Registration  Statement  registering  the  resale of the
Registrable Securities as set forth in the Registration Rights Agreement.

Section  1.10.  "Escrow  Agent"  shall have the  meaning set forth in the Escrow
Agreement.

Section  1.11.   "Escrow   Agreement"   shall  mean  the  Escrow   Agreement  in
substantially   the  form  of   Exhibit   D  hereto   executed   and   delivered
contemporaneously with this Agreement.

Section 1.12.  "Exchange Act" shall mean the Securities Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder.

Section 1.13. "Legend" shall mean the legend set forth in Section 9.1.

Section  1.14.  "Market  Price" on any given date shall mean the  average of the
lowest  prices on the  Principal  Market (as reported by Bloomberg  L.P.) of the
Common  Stock at which a trade is executed on any three (3) Trading  Days during
the  twenty-two  (22) Trading Day period  ending on the Trading Day  immediately
prior to the date for which the Market Price is to be determined.

Section 1.15.  "Material  Adverse Effect" shall mean any effect on the business,
operations, properties, prospects, or financial condition of the Company that is
material and adverse to the Company and its subsidiaries  and affiliates,  taken
as a whole, and/or any condition, circumstance, or situation that would prohibit
or otherwise interfere with the ability of the Company to enter into and perform
any of its obligations under this Agreement,  the Registration Rights Agreement,
the Escrow Agreement,  the Convertible  Debenture or the Warrant in any material
respect.

Section 1.16.  "Outstanding"  when used with reference to shares of Common Stock
or Capital Shares  (collectively  the  "Shares"),  shall mean, at any date as of
which the number of such Shares is to be determined,  all issued and outstanding
Shares,  and shall  include all such Shares  issuable in respect of  outstanding
scrip or any  certificates  representing  fractional  interests  in such Shares;
provided,  however,  that  "Outstanding"  shall  not mean any such  Shares  then
directly or indirectly owned or held by or for the account of the Company.

Section 1.17. "Person" shall mean an individual,  a corporation,  a partnership,
an association, a trust or other entity or organization,  including a government
or political subdivision or an agency or instrumentality thereof.


                                       2
<PAGE>


Section 1.18. "Principal Market" shall mean the American Stock Exchange, the New
York Stock Exchange,  the NASDAQ National Market, the NASDAQ Small-Cap Market or
the NASD OTC  Bulletin  Board,  whichever is at the time the  principal  trading
exchange or market for the Common Stock.

Section 1.19.  "Purchase  Price" shall mean six hundred and one thousand and two
hundred dollars ($601,200) in the aggregate.

Section 1.20. "Registrable  Securities" shall mean the Conversion Shares and the
Warrant  Shares until the earliest to occur of: (i) the  Registration  Statement
has been declared  effective by the SEC, and all  Conversion  Shares and Warrant
Shares have been disposed of pursuant to the  Registration  Statement,  (ii) all
Conversion  Shares and Warrant Shares have been sold under  circumstances  under
which all of the  applicable  conditions  of Rule 144 (or any similar  provision
then in  force)  under  the  Securities  Act  ("Rule  144")  are met,  (iii) all
Conversion Shares and Warrant Shares have been otherwise  transferred to holders
who may trade such shares without  restriction under the Securities Act, and the
Company has delivered a new  certificate or other evidence of ownership for such
securities not bearing a restrictive legend or (iv) such time as, in the opinion
of counsel to the Company,  all Conversion Shares and Warrant Shares may be sold
without any time, volume or manner  limitations  pursuant to Rule 144(k) (or any
similar provision then in effect) under the Securities Act.

Section 1.21. "Registration Rights Agreement" shall mean the agreement regarding
the  filing of the  Registration  Statement  for the  resale of the  Registrable
Securities,  entered into between the Company and the Investor as of the Closing
Date in the form annexed hereto as Exhibit C.

Section 1.22.  "Registration  Statement" shall mean a registration  statement on
Form S-3 (if use of such form is then  available to the Company  pursuant to the
rules of the SEC and,  if not,  on such  other form  promulgated  by the SEC for
which the Company then  qualifies  and which  counsel for the Company shall deem
appropriate, and which form shall be available for the resale of the Registrable
Securities to be registered thereunder in accordance with the provisions of this
Agreement, the Registration Rights Agreement and in accordance with the intended
method of distribution of such  securities),  for the registration of the resale
by the Investor of the Registrable Securities under the Securities Act.

Section 1.23. "Regulation D" shall have the meaning set forth in the recitals of
this Agreement.

Section  1.24.  "SEC"  shall  mean the United  States  Securities  and  Exchange
Commission.

Section 1.25. "Section 4(2)" shall have the meaning set forth in the recitals of
this Agreement.

Section 1.26.  "Securities Act" shall have the meaning set forth in the recitals
of this Agreement.

Section 1.27.  "SEC  Documents"  shall mean the Company's  Annual Report on Form
10-KSB for the fiscal  year  ended  December  31,  1997 and each  report,  proxy
statement or  registration  statement filed by the Company with the SEC pursuant
to the Exchange Act or the Securities Act since the filing of such Annual Report
through the date hereof.

Section 1.28. "Shares" shall have the meaning set forth in Section 1.16

Section 1.29. "Trading Day" shall mean any day during which the Principal Market
at such day shall be open for business.

Section 1.30. "Warrant(s)" shall mean the warrants substantially in the forms of
Exhibit B to be issued to the Investor hereunder. The Exhibit B Warrants, for an
aggregate of 120,000 shares,  are  non-redeemable  and have an Exercise Price of
$1.50 per share.


                                       3
<PAGE>


Section  1.31.  "Warrant  Shares" shall mean all shares of Common Stock or other
securities issued or issuable pursuant to exercise of the Warrants.

                                   ARTICLE II

            Purchase and Sale of Convertible Debentures and Warrants

Section 2.1. Investment.

     (a) Upon the terms and  subject to the  conditions  set forth  herein,  the
Company agrees to sell, and each Investor,  severally and not jointly, agrees to
purchase a Convertible  Debenture and a Warrant at their pro-rata portion of the
Purchase Price on the Closing Date as follows:

           (i) Upon  execution  and delivery of this  Agreement,  each  Investor
               shall deliver to the Escrow Agent immediately  available funds in
               the amount of the Purchase  Price,  and the Company shall deliver
               the  corresponding  Convertible  Debenture and the  corresponding
               Warrant  to the  Escrow  Agent,  in  each  case to be held by the
               Escrow Agent pursuant to the Escrow Agreement.

          (ii) Upon  satisfaction of the conditions set forth in Section 2.1(b),
               the Closing  ("Closing") shall occur at the offices of the Escrow
               Agent at which the Escrow  Agent (x) shall  release the  relevant
               Convertible Debenture and the relevant Warrant to the appropriate
               Investor and (y) shall release the  corresponding  Purchase Price
               (after  all  fees  have  been  paid as set  forth  in the  Escrow
               Agreement)  to the  Company,  pursuant to the terms of the Escrow
               Agreement.

     (b) The Closing is subject to the satisfaction of the following conditions:

           (i) acceptance  and execution by the Company and by both Investors of
               this Agreement and all Exhibits hereto;

          (ii) delivery  into escrow by each Investor of  immediately  available
               funds  in  the  amount  of the  relevant  Purchase  Price  of the
               Convertible Debenture and the Warrant, as more fully set forth in
               the Escrow Agreement;

         (iii) all  representations  and  warranties of each Investor  contained
               herein shall remain true and correct as of the Closing Date (as a
               condition to the Company's obligations);

          (iv) all  representations  and  warranties  of the  Company  contained
               herein shall remain true and correct as of the Closing Date (as a
               condition to each Investor's obligations);

           (v) the Company  shall have  obtained all permits and  qualifications
               required  by any state for the offer and sale of the  Convertible
               Debentures  and  Warrants,  or  shall  have the  availability  of
               exemptions therefrom;

          (vi) the sale and issuance of the Convertible  Debentures and Warrants
               hereunder,  and the  proposed  issuance  by the  Company  to each
               Investor of the Common Stock underlying the Convertible Debenture
               and Warrants  upon the  conversion  or exercise  thereof shall be
               legally  permitted  by all laws  and  regulations  to  which  the
               Investor and the


                                       4
<PAGE>


               Company are  subject  and there  shall be no ruling,  judgment or
               writ of any court  prohibiting the  transactions  contemplated by
               this Agreement;

         (vii) delivery  of all  of  the  original  fully  executed  Convertible
               Debenture and Warrant certificates to the Escrow Agent;

        (viii) receipt by each  Investor  of an  opinion  of Epstein  Becker &
               Green,  P.C..,  counsel to the Company,  in the form of Exhibit E
               hereto;

          (ix) delivery to the Escrow Agent of the  Irrevocable  Instructions to
               Transfer Agent in the form attached hereto as Exhibit F; and

           (x) delivery to each Investor of the Registration Rights Agreement.

Section 2.2.  Allocation.  The Purchase Price shall be allocated $600,000 to the
Convertible Debentures and $1,200 to the Warrants.

Section 2.3. Liquidated  Damages.  The parties hereto acknowledge and agree that
the sum payable pursuant to the  Registration  Rights Agreement shall constitute
liquidated damages and not penalties.  The parties further  acknowledge that (a)
the amount of loss or damages likely to be incurred is incapable or is difficult
to  precisely  estimate,  (b) the  amounts  specified  in such  Sections  bear a
reasonable  proportion  and are not plainly or grossly  disproportionate  to the
probable  loss  likely to be incurred by the  Investor  in  connection  with the
failure  by the  Company to timely  cause the  registration  of the  Registrable
Securities and (c) the parties are sophisticated  business parties and have been
represented by sophisticated and able legal and financial counsel and negotiated
this Agreement at arm's length.

                                  ARTICLE III

                   Representations and Warranties of Investors

Each Investor, severally and not jointly, represents and warrants to the Company
that:

Section 3.1.  Intent.  The Investor is entering into this  Agreement for its own
account  and the  Investor  has no present  arrangement  (whether or not legally
binding)  at any  time to sell  the  Convertible  Debenture,  the  Warrant,  any
Conversion  Shares  or  Warrant  Shares to or  through  any  person  or  entity;
provided,  however, that by making the representations herein, the Investor does
not agree to hold such  securities  for any minimum or other  specific  term and
reserves the right to dispose of the Conversion Shares and Warrant Shares at any
time in accordance  with federal and state  securities  laws  applicable to such
disposition.

Section 3.2.  Sophisticated  Investor.  The Investor is a sophisticated investor
(as described in Rule 506(b)(2)(ii) of Regulation D) and an accredited  investor
(as defined in Rule 501 of  Regulation  D), and Investor has such  experience in
business and financial  matters that it is capable of evaluating  the merits and
risks  of an  investment  in the  Convertible  Debenture,  the  Warrant  and the
underlying  Common Stock.  The Investor  acknowledges  that an investment in the
Convertible   Debenture,   the  Warrant  and  the  underlying  Common  Stock  is
speculative and involves a high degree of risk.

Section 3.3. Authority. This Agreement and each agreement attached as an Exhibit
hereto which is required to be executed by Investor has been duly authorized and
validly  executed  and  delivered  by the  Investor  and is a valid and  binding
agreement of the Investor  enforceable  against it in accordance with its terms,
subject to applicable  bankruptcy,  insolvency,  or similar laws relating to, or
affecting  generally the  enforcement of,  creditors'  rights and remedies or by
other equitable principles of general application.


                                       5
<PAGE>


Section  3.4.  Not an  Affiliate.  The  Investor is not an officer,  director or
"affiliate"  (as that term is defined in Rule 405 of the Securities  Act) of the
Company.

Section 3.5. Absence of Conflicts.  The execution and delivery of this Agreement
and the  agreements  the forms of which are  attached  as  Exhibits  hereto  and
executed by the Investor in connection  herewith,  and the  consummation  of the
transactions   contemplated   hereby  and  thereby,   and  compliance  with  the
requirements thereof, will not violate any law, rule,  regulation,  order, writ,
judgment,  injunction,  decree or award  binding on  Investor or (a) violate any
provision of any indenture, instrument or agreement to which Investor is a party
or is subject,  or by which Investor or any of its assets is bound; (b) conflict
with or constitute a material default thereunder;  (c) result in the creation or
imposition of any lien pursuant to the terms of any such  indenture,  instrument
or agreement,  or constitute a breach of any fiduciary  duty owed by Investor to
any third party; or (d) require the approval of any  third-party  (which has not
been  obtained)  pursuant  to  any  material  contract,  agreement,  instrument,
relationship or legal obligation to which Investor is subject or to which any of
its assets, operations or management may be subject.

Section 3.6.  Disclosure;  Access to Information.  The Investor has received all
documents, records, books and other publicly available information pertaining to
Investor's  investment in the Company that have been  requested by the Investor.
Investor  acknowledges  that the  Company is subject to the  periodic  reporting
requirements  of the  Exchange  Act,  and the  Investor has reviewed or received
copies of all SEC Documents that have been requested by it. Section

3.7.  Manner of Sale. At no time was Investor  presented with or solicited by or
through any leaflet, public promotional meeting, television advertisement or any
other form of general solicitation or advertising by the Company. 

                                   ARTICLE IV

                  Representations and Warranties of the Company

The Company represents and warrants to the Investors that:

Section 4.1.  Organization  of the Company.  The Company is a  corporation  duly
incorporated  and  existing  in good  standing  under  the laws of the  State of
Florida and has all requisite  corporate  authority to own its properties and to
carry on its  business as now being  conducted.  The  Company  does not have any
subsidiaries  and does not own more that fifty  percent  (50%) of or control any
other business  entity except as set forth in the SEC Documents.  The Company is
duly  qualified and is in good standing as a foreign  corporation to do business
in every  jurisdiction in which the nature of the business conducted or property
owned by it makes such  qualification  necessary,  other than those in which the
failure so to qualify would not have a Material Adverse Effect.

Section 4.2.  Authority.  (i) The Company has the requisite  corporate power and
corporate  authority  to enter  into and  perform  its  obligations  under  this
Agreement,  the Registration  Rights Agreement,  the Escrow  Agreement,  and the
Warrants and to issue the Convertible  Debentures,  the Conversion  Shares,  the
Warrants and the Warrant Shares  pursuant to their  respective  terms,  (ii) the
execution,  issuance and delivery of this  Agreement,  the  Registration  Rights
Agreement,  the Escrow Agreement, the Convertible Debentures and the Warrants by
the Company and the consummation by it of the transactions  contemplated  hereby
have been duly  authorized  by all  necessary  corporate  action  and no further
consent  or   authorization  of  the  Company  or  its  Board  of  Directors  or
shareholders is required,  and (iii) this  Agreement,  the  Registration  Rights
Agreement,  the Escrow  Agreement,  the Convertible  Debentures and the Warrants
have been duly  executed and  delivered by the Company and at the Closing  shall
constitute valid and binding  obligations of the Company enforceable against the
Company in accordance  with their terms,  except as such  enforceability  may be
limited by  applicable  bankruptcy,  insolvency,  moratorium,  or  similar  laws
relating to, or affecting



                                       6
<PAGE>


generally  the  enforcement  of,  creditors'  rights  and  remedies  or by other
equitable  principles of general  application.  The Company has duly and validly
authorized and reserved for issuance shares of Common Stock sufficient in number
for the  conversion of the  Convertible  Debentures  (assuming a Market Price of
$1.00)  and for the  exercise  of the  Warrants.  The  Company  understands  and
acknowledges the potentially dilutive effect to the Common Stock of the issuance
of  the  Conversion   Shares  and  the  Warrant  Shares.   The  Company  further
acknowledges  that its obligation to issue Conversion  Shares upon conversion of
the  Convertible  Debenture and Warrant  Shares upon exercise of the Warrants in
accordance with this Agreement is absolute and  unconditional  regardless of the
dilutive effect that such issuance may have on the ownership  interests of other
shareholders  of the Company and  notwithstanding  the  commencement of any case
under 11 U.S.C. ss. 101 et seq. (the "Bankruptcy  Code").  The Company shall not
seek  judicial  relief from its  obligations  hereunder  except  pursuant to the
Bankruptcy Code. In the event the Company is a debtor under the Bankruptcy Code,
the Company hereby waives to the fullest  extent  permitted any rights to relief
it may have  under  11  U.S.C.  ss.  362 in  respect  of the  conversion  of the
Convertible  Debentures  and the exercise of the Warrants.  The Company  agrees,
without  cost or  expense  to the  Investor,  to take or  consent to any and all
action necessary to effectuate relief under 11 U.S.C. ss. 362.

Section  4.3.  Capitalization.  The  authorized  capital  stock  of the  Company
consists of 15,000,000  shares of Common Stock, no par value per share, of which
approximately  7,626,000  shares are issued and  outstanding  as of January  31,
1999,  1,000,000  shares of preferred stock, no par value per share, of which no
shares are issued  and  outstanding,  and  approximately  1,345,000  outstanding
Common  Stock  purchase  warrants or  securities  convertible  into Common stock
issued and  outstanding.  Except for  outstanding  options to acquire a total of
335,000  shares  of  Common  Stock as of  January  31,  1999  there are no other
outstanding Capital Shares Equivalents.  All of the outstanding shares of Common
Stock of the Company  have been duly and validly  authorized  and issued and are
fully paid and non-assessable.

Section 4.4. Common Stock.  The Company has registered its Common Stock pursuant
to  Section  12(g)  of the  Exchange  Act and is in  full  compliance  with  all
reporting  requirements  of the Exchange  Act, and the Company is in  compliance
with all  requirements  for the  continued  listing or  quotation  of its Common
Stock,  and such Common  Stock is  currently  listed or quoted on the  Principal
Market.  As of the date hereof,  the  Principal  Market is the NASD OTC Bulletin
Board Market and the Company has not received any notice  regarding,  and to its
knowledge  there is no  threat,  of the  termination  or  discontinuance  of the
eligibility of the Common Stock for such listing.

Section 4.5. SEC  Documents.  The Company has delivered or made available to the
Investors by EDGAR true and complete  copies of the SEC  Documents.  The Company
has not provided to the Investors any information that,  according to applicable
law, rule or regulation,  should have been disclosed  publicly prior to the date
hereof  by the  Company,  but  which  has not  been so  disclosed.  As of  their
respective  dates, the SEC Documents  complied in all material respects with the
requirements  of the  Exchange  Act,  and  rules  and  regulations  of  the  SEC
promulgated  thereunder  and  the  SEC  Documents  did not  contain  any  untrue
statement  of a material  fact or omit to state a material  fact  required to be
stated therein or necessary in order to make the statements therein, in light of
the  circumstances  under which they were made,  not  misleading.  The financial
statements  of  the  Company  included  in the  SEC  Documents  (the  "Financial
Statements")  complied  in all  material  respects  with  applicable  accounting
requirements  and the  published  rules  and  regulations  of the  SEC or  other
applicable  rules  and  regulations  with  respect  thereto  at the time of such
inclusion.  Such  Financial  Statements  have been prepared in  accordance  with
generally  accepted  accounting  principles applied on a consistent basis during
the periods involved (except (i) as may be otherwise indicated in such Financial
Statements  or the  notes  thereto  or (ii) in the  case  of  unaudited  interim
statements,  to the extent they exclude footnotes or may be condensed or summary
statements) and fairly present in all material  respects the financial  position
of the Company as of the dates  thereof and the results of  operations  and cash
flows for the periods  then ended  (subject,  in the case of  unaudited  interim
statements,  to normal year-end audit adjustments).  Except for the indebtedness
of the Company being repaid at the Closing and as otherwise



                                       7
<PAGE>


reflected  in the SEC Reports,  neither the Company nor any of its  subsidiaries
has any material  indebtedness,  obligations or liabilities of any kind (whether
accrued,  absolute,  contingent or otherwise,  and whether due or to become due)
that would have been required to be reflected in, reserved  against or otherwise
described in the Financial Statements or in the notes thereto in accordance with
GAAP, which was not fully reflected in, reserved against or otherwise  described
in the SEC Documents,  Financial Statements or the notes thereto included in the
SEC Documents or was not incurred in the ordinary course of business  consistent
with  the  Company's  past  practices  since  the  last  date of such  Financial
Statements.

Section  4.6.  Exemption  from  Registration;  Valid  Issuances.  Subject to the
accuracy  of the  Investor's  representations  in Article  III,  the sale of the
Convertible  Debentures,  the  Conversion  Shares,  the Warrants and the Warrant
Shares  will not  require  registration  under the  Securities  Act  and/or  any
applicable  state  securities  law. When issued and paid for in accordance  with
each  Warrant and each  Convertible  Debenture,  the  Conversion  Shares and the
Warrant Shares will be duly and validly issued,  fully paid, and non-assessable.
Neither the sales of the  Convertible  Debentures,  the Conversion  Shares,  the
Warrants or the Warrant Shares pursuant to, nor the Company's performance of its
obligations under, this Agreement, the Registration Rights Agreement, the Escrow
Agreement,  the Convertible  Debentures,  or the Warrants will (i) result in the
creation or  imposition  by the Company of any liens,  charges,  claims or other
encumbrances upon the Convertible Debentures, the Conversion Shares, the Warrant
Shares or, except as contemplated  herein, any of the assets of the Company,  or
(ii) entitle the holders of  Outstanding  Capital  Shares to preemptive or other
rights to subscribe to or acquire the Capital Shares or other  securities of the
Company.  The Convertible  Debentures,  the Conversion  Shares,  and the Warrant
Shares  shall not subject the  Investor to personal  liability to the Company or
its creditors by reason of the possession thereof.

Section  4.7.  No  General   Solicitation  or  Advertising  in  Regard  to  this
Transaction.  Neither the Company nor any of its  Affiliates (as defined in Rule
405 under the  Securities  Act) nor any person acting on its or their behalf (i)
has conducted or will conduct any general  solicitation (as that term is used in
Rule  502(c) of  Regulation  D) or general  advertising  with  respect to of the
Convertible  Debentures or the Warrants, or (ii) made any offers or sales of any
security or  solicited  any offers to buy any security  under any  circumstances
that would require  registration of the Convertible  Debentures,  the Conversion
Shares, the Warrants or the Warrant Shares under the Securities Act.

Section 4.8. Corporate Documents. The Company has furnished or made available to
the Investor true and correct copies of the Company's Articles of Incorporation,
as amended and in effect on the date hereof (the "Articles"),  and the Company's
By-Laws, as amended and in effect on the date hereof (the "By-Laws").

Section 4.9. No Conflicts.  Except as set forth on Schedule 4.9, the  execution,
delivery and  performance of this Agreement by the Company and the  consummation
by the  Company  of the  transactions  contemplated  hereby,  including  without
limitation the issuance of the Convertible  Debentures,  the Conversion  Shares,
the  Warrants  and the  Warrant  Shares,  do not and  will not (i)  result  in a
violation of the Company's  Articles of Incorporation or By-laws,  (ii) conflict
with, or constitute a material default (or an event that with notice or lapse of
time or both  would  become a  default)  under,  or give to others any rights of
termination, amendment, acceleration or cancellation of, any material agreement,
indenture  or  instrument,   or  any  "lock-up"  or  similar  provision  of  any
underwriting  or similar  agreement  to which the  Company is a party,  or (iii)
result in a violation  of any  federal,  state or local law,  rule,  regulation,
order,  judgment  or decree  (including  federal and state  securities  laws and
regulations)  applicable  to the  Company or by which any  material  property or
asset of the  Company is bound or  affected,  nor is the  Company  otherwise  in
violation of,  conflict  with or default  under any of the foregoing  (except in
each case for such conflicts, defaults, terminations, amendments, accelerations,
cancellations  and  violations  as  would  not  have,  individually  or  in  the
aggregate,  a Material Adverse Effect). The business of the Company is not being
conducted in violation of any law,  ordinance or regulation of any  governmental
entity,  except for possible  violations  that either singly or in the aggregate
would not have a Material  Adverse  Effect.  The Company is not  required  under
federal, state or local law,


                                       8
<PAGE>


rule or regulation to obtain any consent, authorization or order of, or make any
filing or registration with, any court or governmental agency in order for it to
execute, deliver or perform any of its obligations under this Agreement or issue
and sell the Convertible Debentures or the Warrants in accordance with the terms
hereof (other than any SEC, Nasdaq Stock Market or state securities filings that
may  be  required  to  be  made  by  the  Company  subsequent  to  Closing,  any
registration  statement that may be filed pursuant  hereto,  and any shareholder
approval required by the rules applicable to companies whose common stock trades
on the Nasdaq Stock Market);  provided that, for purposes of the  representation
made in this sentence,  the Company is assuming and relying upon the accuracy of
the relevant representations and agreements of each Investor herein.

Section 4.10. No Material Adverse Change.  Since September 30, 1998, no Material
Adverse  Effect has occurred or exists with  respect to the  Company,  except as
disclosed in the SEC Documents.

Section 4.11. No Undisclosed Events or Circumstances.  Since September 30, 1998,
no event or  circumstance  has occurred or exists with respect to the Company or
its businesses,  properties, prospects, operations or financial condition, that,
under  applicable  law,  rule  or  regulation,  requires  public  disclosure  or
announcement  prior to the date  hereof by the Company but which has not been so
publicly announced or disclosed in the SEC Documents.

Section  4.12.  No  Integrated  Offering.  Other than  pursuant to an  effective
registration  statement under the Securities Act, or pursuant to the issuance or
exercise of employee  stock  options,  or  pursuant to its  discussion  with the
Investors in connection with the transactions  contemplated  hereby, the Company
has not issued, offered or sold the Convertible Debentures,  the Warrants or any
shares of Common Stock (including for this purpose any securities of the same or
a similar class as the Convertible Debentures,  the Warrants or Common Stock, or
any  securities   convertible   into  a  exchangeable  or  exercisable  for  the
Convertible  Debentures or Common Stock or any such other securities) within the
six-month  period next  preceding  the date  hereof,  and the Company  shall not
permit any of its  directors,  officers or Affiliates  directly or indirectly to
take, any action  (including,  without  limitation,  any offering or sale to any
person or entity of the  Convertible  Debentures,  Warrants  or shares of Common
Stock), so as to make unavailable the exemption from Securities Act registration
being relied upon by the Company for the offer and sale to the  Investors of the
Convertible  Debentures  (and the  Conversion  Shares) or the Warrants  (and the
Warrant Shares) as contemplated by this Agreement

Section 4.13.  Litigation and Other Proceedings.  Except as disclosed in the SEC
Documents,  there are no lawsuits or proceedings pending or, to the knowledge of
the Company,  threatened,  against the Company, nor has the Company received any
written or oral notice of any such action,  suit,  proceeding or  investigation,
which could reasonably be expected to have a Material Adverse Effect.  Except as
set forth in the SEC Documents,  no judgment,  order, writ, injunction or decree
or award has been issued by or, to the  knowledge of the  Company,  requested of
any court,  arbitrator or  governmental  agency which could result in a Material
Adverse Effect.

Section 4.14. No  Misleading  or Untrue  Communication.  The Company and, to the
knowledge of the Company, any person representing the Company, have not made, at
any time,  any oral  communication  in connection  with the offer or sale of the
Convertible  Debentures and the Warrants which contained any untrue statement of
a material fact or omitted to state any material fact necessary in order to make
the statements,  in the light of the  circumstances  under which they were made,
not misleading.

Section 4.15. Material Non-Public Information.  The Company has not disclosed to
either  Investor  any material  non-public  information  that (i) if  disclosed,
would,  or could  reasonably be expected to have, a material effect on the price
of the Common Stock or (ii)  according to applicable  law,  rule or  regulation,

                                       9
<PAGE>


should have been disclosed  publicly by the Company prior to the date hereof but
which has not been so disclosed.

Section 4.16.  Insurance.  The Company maintains property and casualty,  general
liability,  workers'  compensation,  environmental  hazard,  personal injury and
other similar types of insurance with financially  sound and reputable  insurers
that is adequate,  consistent with the Company's  historical claims  experience.
The Company has not received notice from, and has no knowledge of any threat by,
any insurer  (that has issued any  insurance  policy to the  Company)  that such
insurer  intends to deny coverage under or cancel,  discontinue or not renew any
insurance policy presently in force.

Section 4.17. Tax Matters.

     (a) The  Company  has filed all Tax  Returns  which it is  required to file
under applicable laws, except where the failure to file any Tax Return would not
have a Material Adverse Effect on the Company; all such Tax Returns are true and
accurate and have been  prepared in compliance  with all  applicable  laws;  the
Company  has paid all Taxes due and owing by it  (whether  or not such Taxes are
required  to be shown on a Tax Return)  and have  withheld  and paid over to the
appropriate  taxing  authorities all Taxes which it is required to withhold from
amounts  paid or owing to any  employee,  shareholder,  creditor  or other third
parties;  and since  December 31, 1997,  the charges,  accruals and reserves for
Taxes with respect to the Company  (including any provisions for deferred income
taxes)  reflected  on the books of the  Company  are  adequate  to cover any Tax
liabilities of the Company if its current tax year were treated as ending on the
date hereof.

     (b) No claim has been made by a taxing  authority in a  jurisdiction  where
the Company does not file tax returns that such corporation is or may be subject
to taxation by that jurisdiction.  There are no foreign, federal, state or local
tax audits or administrative or judicial  proceedings pending or being conducted
with  respect to the  Company;  no  information  related to Tax matters has been
requested by any foreign,  federal, state or local taxing authority; and, except
as disclosed  above, no written notice  indicating an intent to open an audit or
other review has been received by the Company from any foreign,  federal,  state
or local taxing authority.  There are no material unresolved questions or claims
concerning  the  Company's  Tax  liability.  The Company (A) has not executed or
entered into a closing  agreement  pursuant to ss. 7121 of the Internal  Revenue
Code or any  predecessor  provision  thereof or any similar  provision of state,
local or  foreign  law;  or (B) has not  agreed  to or is  required  to make any
adjustments  pursuant to ss. 481 (a) of the Internal Revenue Code or any similar
provision  of state,  local or foreign  law by reason of a change in  accounting
method  initiated by the Company or any of its subsidiaries or has any knowledge
that the IRS has proposed any such adjustment or change in accounting method, or
has any application pending with any taxing authority requesting  permission for
any changes in  accounting  methods that relate to the business or operations of
the  Company.  The Company has not been a United  States real  property  holding
corporation  within the meaning of ss.  897(c)(2) of the  Internal  Revenue Code
during the applicable period specified in ss.  897(c)(1)(A)(ii)  of the Internal
Revenue Code.

     (c) The Company has not made an election  under ss.  341(f) of the Internal
Revenue Code.  The Company is not liable for the Taxes of another person that is
not a  subsidiary  of the  Company  under  (A)  Treas.  Reg.  ss.  1.1502-6  (or
comparable  provisions of state,  local or foreign law),  (B) as a transferee or
successor,  (C) by contract or indemnity or (D) otherwise.  The Company is not a
party to any tax sharing  agreement.  The Company has not made any payments,  is
obligated to make payments or is a party to an agreement  that could obligate it
to make any payments that would not be deductible under ss. 280G of the Internal
Revenue Code.

     (d) For purposes of this Section 4.17:


          "IRS" means the United States Internal Revenue Service.


                                       10
<PAGE>


          "Tax" or "Taxes" means federal,  state,  county,  local,  foreign,  or
          other income, gross receipts, ad valorem, franchise, profits, sales or
          use,   transfer,   registration,   excise,   utility,   environmental,
          communications,  real or personal  property,  capital stock,  license,
          payroll,  wage or  other  withholding,  employment,  social  security,
          severance, stamp, occupation, alternative or add-on minimum, estimated
          and other taxes of any kind whatsoever (including, without limitation,
          deficiencies,  penalties,  additions to tax, and interest attributable
          thereto) whether disputed or not.

          "Tax  Return"  means any  return,  information  report or filing  with
          respect  to  Taxes,  including  any  schedules  attached  thereto  and
          including any amendment thereof.

Section 4.18. Property. Neither the Company nor any of its subsidiaries owns any
real property except as disclosed in the SEC Documents.  Each of the Company and
its subsidiaries has good and marketable title to all personal property owned by
it, free and clear of all liens,  encumbrances and defects except such as do not
materially  affect the value of such  property and do not  materially  interfere
with the use made and proposed to be made of such property by the Company;  and,
except  as set forth in  Schedule  4.18,  to the  Company's  knowledge  any real
property and buildings  held under lease by the Company as tenant are held by it
under valid,  subsisting and enforceable  leases with such exceptions as are not
material and do not interfere  with the use made and intended to be made of such
property and buildings by the Company.

Section 4.19.  Intellectual  Property.  Each of the Company and its subsidiaries
owns or possesses  adequate and  enforceable  rights to use all patents,  patent
applications,  trademarks,  trademark applications,  trade names, service marks,
copyrights, copyright applications,  licenses, know-how (including trade secrets
and  other   unpatented   and/or   unpatentable   proprietary  or   confidential
information,  systems or procedures)  and other similar  rights and  proprietary
knowledge  (collectively,  "Intangibles")  necessary  for  the  conduct  of  its
business as now being conducted. To the Company's knowledge, except as disclosed
in the  SEC  Documents  neither  the  Company  nor  any of its  subsidiaries  is
infringing  upon or in conflict  with any right of any other person with respect
to any  Intangibles.  Except as disclosed in the SEC  Documents,  no claims have
been asserted by any person to the ownership or use of any  Intangibles  and the
Company has no knowledge of any basis for such claim.

Section 4.20. Internal Controls and Procedures.  The Company maintains books and
records and internal accounting controls which provide reasonable assurance that
(i) all  transactions to which the Company is a party or by which its properties
are  bound are  executed  with  management's  authorization;  (ii) the  recorded
accounting of the Company's  assets is compared with existing  assets at regular
intervals;  (iii) access to the Company's assets is permitted only in accordance
with management's authorization;  and (iv) all transactions to which the Company
is a party or by which its  properties  are bound are  recorded as  necessary to
permit preparation of the financial statements of the Company in accordance with
U.S. generally accepted accounting principles.

Section  4.21.  Payments and  Contributions.  Neither the Company nor any of its
directors,  officers  or, to its  knowledge,  other  employees  has (i) used any
Company funds for any unlawful contribution, endorsement, gift, entertainment or
other unlawful expense relating to political  activity;  (ii) made any direct or
indirect unlawful payment of Company funds to any foreign or domestic government
official or employee;  (iii) violated or is in violation of any provision of the
Foreign  Corrupt  Practices  Act of 1977,  as  amended;  or (iv) made any bribe,
rebate,  payoff,  influence  payment,  kickback or other similar  payment to any
person with respect to Company matters.

Section 4.22. No Misrepresentation. No representation or warranty of the Company
contained  in this  Agreement,  any  schedule,  annex or  exhibit  hereto or any
agreement,  instrument or certificate  furnished by the Company to the Investors
pursuant to this Agreement,  contains any untrue statement of a material fact or

                                       11
<PAGE>


omits to state a material  fact  required to be stated  therein or  necessary to
make the statements therein, in light of the circumstances under which they were
made, not misleading.

                                    ARTICLE V

                           Covenants of the Investors

Each Investor,  severally and not jointly, covenants and agrees with the Company
as follows:

Section 5.1. Compliance with Law. The Investor's trading activities with respect
to  shares  of the  Company's  Common  Stock  will  be in  compliance  with  all
applicable  state and federal  securities  laws, rules and regulations and rules
and regulations of the Principal  Market on which the Company's  Common Stock is
listed.

Section 5.2.  Restriction on Amount of Conversion  Shares.  Notwithstanding  the
provisions of the Debenture and Warrant  Purchase  Agreement or of the Warrants,
in no event  other than a  Mandatory  Conversion  as defined in the  Convertible
Debenture  or while there is  outstanding  a tender  offer for any or all of the
shares of the Company's Common Stock shall the holder be entitled,  or shall the
Company  have the  obligation,  to convert all or any portion of this  Debenture
(and the Company  shall not have the right to pay  interest  on the  Convertible
Debenture) to the extent that, after such conversion,  the sum of (1) the number
of shares of Common  Stock  beneficially  owned by the Buyer and its  Affiliates
(other  than  shares of Common  Stock  which  may be deemed  beneficially  owned
through  the  ownership  of  the  unconverted   portion  of  the  Debentures  or
unexercised  portion  of the  Warrants),  and (2) the number of shares of Common
Stock issuable upon the conversion of the Debentures or exercise of the Warrants
with respect to which the  determination  of this  proviso is being made,  would
result in  beneficial  ownership  by the Buyer and its  affiliates  of more than
9.99% of the  outstanding  shares of Common Stock (after taking into account the
shares to be issued to the Buyer upon such conversion or exercise). For purposes
of the immediately preceding sentence,  beneficial ownership shall be determined
in  accordance  with Section  13(d) of the  Securities  Exchange Act of 1934, as
amended (the "1934 Act") and Regulation  13D-G  thereunder,  except as otherwise
provided in clause (1) of such  sentence.  The Buyer further  agrees that if the
Buyer transfers or assigns any of the Debentures or all or any part of a Warrant
to a party who or which would not be considered  an Affiliate,  such transfer or
assignment  shall be made subject to the  transferee's  or  assignee's  specific
agreement to be bound the  provisions of this Section 5.2 as if such  transferee
or assignee were a signatory to this Agreement.

                                   ARTICLE VI

                            Covenants of the Company

Section  6.1.  Registration  Rights.  The Company  shall cause the  Registration
Rights Agreement to remain in full force and effect and the Company shall comply
in all material respects with the terms thereof.

Section 6.2. Reservation of Common Stock. As of the date hereof, the Company has
reserved  and the Company  shall  continue to reserve and keep  available at all
times,  free of  preemptive  rights,  shares of Common  Stock for the purpose of
enabling  the  Company to issue the  Conversion  Shares and the  Warrant  Shares
pursuant to any  conversion  of the  Convertible  Debentures  or exercise of the
Warrants up to the maximum  number of shares of Common Stock  authorized  in the
Company's Certificate of Incorporation; such amount of shares of Common Stock to
be reserved  shall be calculated  based upon a Market Price for the Common Stock
under the terms of the Debenture of $1.00. The number of shares so reserved from
time to


                                       12
<PAGE>


time,  as  theretofore  increased  or reduced as  hereinafter  provided,  may be
reduced by the number of shares actually delivered pursuant to any conversion of
a  Convertible  Debenture  or  exercise of a Warrant and the number of shares so
reserved  shall be  increased or  decreased  to reflect  potential  increases or
decreases  in the Common Stock that the Company may  thereafter  be obligated to
issue by reason of adjustments to the Warrants.

Section 6.3.  Listing of Common Stock. The Company hereby agrees to maintain the
listing of the Common Stock on a Principal  Market,  and as soon as permitted by
the rules of the Principal Market, to list the Conversion Shares and the Warrant
Shares on the  Principal  Market.  The Company  further  agrees,  if the Company
applies to have the Common Stock traded on any other Principal  Market,  it will
include in such  application the Conversion  Shares and the Warrant Shares,  and
will take such other  action as is  necessary  or  desirable  in the  opinion of
either  Investor to cause the Common Stock to be listed on such other  Principal
Market as promptly as possible. The Company will take all action to continue the
listing  and  trading  of its Common  Stock on a  Principal  Market  (including,
without limitation,  maintaining sufficient net tangible assets) and will comply
in all respects with the Company's reporting, filing and other obligations under
the bylaws or rules of the Principal Market and shall provide each Investor with
copies of any correspondence to or from such Principal Market which questions or
threatens  delisting of the Common  Stock,  within three (3) Trading Days of the
Company's  receipt  thereof,  until  the  Investor  has  disposed  of all of its
Registrable  Securities.  The Chief  Executive  Officer of the  Company,  by his
execution  of this  Agreement  on  behalf  of the  Company,  agrees  to vote his
personal shares of the Company's Common Stock in favor of any such proposal.

Section 6.4. Exchange Act Registration.  The Company will cause its Common Stock
to continue to be  registered  under  Section  12(b) or (g) of the Exchange Act,
will use its best efforts to comply in all material  respects with its reporting
and filing  obligations  under the Exchange Act, and will not take any action or
file any  document  (whether or not  permitted  by the Exchange Act or the rules
thereunder) to terminate or suspend such registration or to terminate or suspend
its  reporting  and filing  obligations  under said Act until each  Investor has
disposed of all of its Registrable Securities.

Section 6.5.  Legends.  The certificates  evidencing the Registrable  Securities
shall be free of legends, except as set forth in Article IX.

Section 6.6. Corporate  Existence.  The Company will take all steps necessary to
preserve and continue the corporate existence of the Company.

Section 6.7. Consolidation; Merger. The Company shall not, at any time after the
date hereof,  effect any merger or consolidation of the Company with or into, or
a transfer of all or substantially  all of the assets of the Company to, another
entity (a  "Consolidation  Event")  unless the resulting  successor or acquiring
entity (if not the Company) assumes by written instrument or by operation of law
the obligation to deliver to the Investor such shares of stock and/or securities
as the Investor is entitled to receive pursuant to this Agreement.

Section 6.8. Private Offering Exemption.  The sale of the Convertible  Debenture
and the issuance of the Warrant  Shares  pursuant to exercise of the Warrant and
the Conversion Shares upon conversion of the Convertible Debenture shall be made
in  accordance  with the  provisions  and  requirements  of Section  4(2) of the
Securities  Act,  Regulation D promulgated  thereunder and any applicable  state
securities  law. The Company shall make all necessary SEC and "blue sky" filings
required to be made by the Company in connection with the sale of the Securities
to the Investors as required by all  applicable  Laws,  and shall provide a copy
thereof to the Investors promptly after such filing.


                                       13
<PAGE>


                                  ARTICLE VII

                            Survival; Indemnification

Section 7.1.  Survival.  The  representations,  warranties and covenants made by
each of the Company and each Investor in this Agreement, the annexes,  schedules
and exhibits hereto and in each  instrument,  agreement and certificate  entered
into and delivered by them pursuant to this Agreement, shall survive the Closing
and the consummation of the transactions  contemplated hereby. In the event of a
breach or violation of any of such representations, warranties or covenants, the
party to whom such representations, warranties or covenants have been made shall
have all rights and remedies for such breach or violation  available to it under
the  provisions  of this  Agreement or  otherwise,  whether at law or in equity,
irrespective of any investigation made by or on behalf of such party on or prior
to the Closing Date. 

Section 7.2.  Indemnity.  (a) The Company  hereby  agrees to indemnify  and hold
harmless each Investor, its Affiliates and their respective officers, directors,
partners  and  members  (collectively,  the  "Investor  Indemnitees"),  from and
against any and all Damages,  in each case  promptly as incurred by the Investor
Indemnitees and to the extent arising out of or in connection with:

          (i) any  misrepresentation,  omission  of fact or breach of any of the
     Company's  representations or warranties  contained in this Agreement,  the
     annexes,  schedules  or exhibits  hereto or any  instrument,  agreement  or
     certificate  entered  into or  delivered  by the  Company  pursuant to this
     Agreement; or

          (ii) any failure by the Company to perform in any material respect any
     of its covenants, agreements, undertakings or obligations set forth in this
     Agreement,  the annexes,  schedules or exhibits  hereto or any  instrument,
     agreement or certificate  entered into or delivered by the Company pursuant
     to this  Agreement. 

     (b) Each  Investor,  severally and not jointly,  hereby agrees to indemnify
and hold harmless the Company,  its  Affiliates and their  respective  officers,
directors, partners and members (collectively, the "Company Indemnitees"),  from
and against any and all Damages, and agrees to reimburse the Company Indemnitees
for reasonable all  out-of-pocket  expenses  (including the reasonable  fees and
expenses  of legal  counsel),  in each case  promptly as incurred by the Company
Indemnitees and to the extent arising out of or in connection with:

          (i) any  misrepresentation,  omission of fact, or breach of any of the
     Investor's  representations or warranties contained in this Agreement,  the
     annexes,  schedules  or exhibits  hereto or any  instrument,  agreement  or
     certificate  entered into or  delivered  by the  Investor  pursuant to this
     Agreement; or

          (ii) any failure by the  Investor to perform in any  material  respect
     any of its covenants, agreements,  undertakings or obligations set forth in
     this Agreement or any instrument,  certificate or agreement entered into or
     delivered by the Investor pursuant to this Agreement.

Section 7.3.  Notice.  Promptly  after  receipt by either  party hereto  seeking
indemnification  pursuant  to Section  7.2 (an  "Indemnified  Party") of written
notice of any  investigation,  claim,  proceeding  or other action in respect of
which  indemnification is being sought (each, a "Claim"),  the Indemnified Party
promptly shall notify the party against whom indemnification pursuant to Section
7.2 is being sought (the "Indemnifying  Party") of the commencement thereof; but
the omission to so notify the  Indemnifying  Party shall not relieve it from any
liability  that it otherwise may have to the  Indemnified  Party,  except to the
extent  that  the  Indemnifying  Party is  materially  prejudiced  and  forfeits
substantive  rights and defenses by reason of such failure.  In connection  with
any Claim as to which both the Indemnifying  Party and the Indemnified Party are
parties, the Indemnifying Party shall be entitled to assume the defense thereof.
Notwithstanding  the assumption of the defense of any Claim by the  Indemnifying
Party,  the  Indemnified  Party  shall have the right to employ  separate  legal
counsel and to participate in the defense of such


                                       14
<PAGE>


Claim, and the Indemnifying Party shall bear the reasonable fees,  out-of-pocket
costs and expenses of such separate  legal counsel to the  Indemnified  Party if
(and only if):  (x) the  Indemnifying  Party shall have agreed to pay such fees,
out-of-pocket costs and expenses, (y) the Indemnified Party and the Indemnifying
Party  reasonably  shall have concluded that  representation  of the Indemnified
Party  and the  Indemnifying  Party  by the  same  legal  counsel  would  not be
appropriate  due to actual or, as reasonably  determined by legal counsel to the
Indemnified Party,  potentially  differing interests between such parties in the
conduct  of the  defense  of such  Claim,  or if  there  may be  legal  defenses
available to the  Indemnified  Party that are in addition to or  disparate  from
those available to the Indemnifying  Party, or (z) the Indemnifying  Party shall
have failed to employ legal counsel  reasonably  satisfactory to the Indemnified
Party within a reasonable  period of time after  notice of the  commencement  of
such  Claim.  If  the  Indemnified  Party  employs  separate  legal  counsel  in
circumstances  other than as described  in clauses  (x),  (y) or (z) above,  the
fees, costs and expenses of such legal counsel shall be borne exclusively by the
Indemnified  Party.  Except as provided above, the Indemnifying Party shall not,
in connection  with any Claim in the same  jurisdiction,  be liable for the fees
and expenses of more than one firm of legal  counsel for the  Indemnified  Party
(together with appropriate  local counsel).  The  Indemnifying  Party shall not,
without the prior written consent of the Indemnified  Party (which consent shall
not unreasonably be withheld),  settle or compromise any Claim or consent to the
entry of any  judgment  that does not  include an  unconditional  release of the
Indemnified Party from all liabilities with respect to such Claim or judgment.

Section 7.4. Direct Claims. In the event one party hereunder should have a claim
for indemnification  that does not involve a claim or demand being asserted by a
third party,  the Indemnified  Party promptly shall deliver notice of such claim
to the  Indemnifying  Party. If the Indemnified  Party disputes the claim,  such
dispute shall be resolved by mutual  agreement of the Indemnified  Party and the
Indemnifying  Party or by binding  arbitration  conducted in accordance with the
procedures  and rules of the American  Arbitration  Association  as set forth in
Article X. Judgment upon any award rendered by any arbitrators may be entered in
any court having competent jurisdiction thereof.

                                  ARTICLE VIII

         Due Diligence Review; Non-Disclosure of Non-Public Information

Section 8.1. Due  Diligence  Review.  Subject to Section 8.2, the Company  shall
make  available  for  inspection  and review by each  Investor,  advisors to and
representatives  of the  Investors  (who  may or may not be  affiliated  with an
Investor and who are  reasonably  acceptable  to the Company),  any  underwriter
participating  in any disposition of the Registrable  Securities on behalf of an
Investor pursuant to the Registration Statement, any such registration statement
or amendment or supplement  thereto or any blue sky, Nasdaq or other filing, all
SEC Documents and other filings with the SEC, and all other  publicly  available
corporate documents and properties of the Company as may be reasonably necessary
for the purpose of such review, and cause the Company's officers,  directors and
employees to supply all such publicly available information reasonably requested
by an Investor or any such representative,  advisor or underwriter in connection
with such Registration Statement (including,  without limitation, in response to
all questions and other inquiries  reasonably made or submitted by any of them),
prior to and  from  time to time  after  the  filing  and  effectiveness  of the
Registration  Statement  for the sole purpose of enabling such Investor and such
representatives,  advisors and underwriters and their respective accountants and
attorneys  to conduct  initial  and ongoing due  diligence  with  respect to the
Company and the accuracy of the Registration Statement.


                                       15
<PAGE>


Section 8.2. Non-Disclosure of Non-Public Information.

     (a) The Company shall not disclose material  non-public  information to the
Investors,  advisors to or  representatives  of the  Investors  unless  prior to
disclosure of such information the Company  identifies such information as being
non-public   information   and  provides  the   Investors,   such  advisors  and
representatives  with the  opportunity  to  accept  or  refuse  to  accept  such
non-public  information for review. Other than disclosure of any comment letters
received  from the SEC staff with  respect to the  Registration  Statement,  the
Company may, as a condition to disclosing any non-public  information hereunder,
require  the   Investors'   advisors  and   representatives   to  enter  into  a
confidentiality agreement in form reasonably satisfactory to the Company and the
Investors.

     (b)  Nothing  herein  shall  require  the  Company  to  disclose   material
non-public  information to the Investors or their  advisors or  representatives,
and the Company  represents  that it does not  disseminate  material  non-public
information  to any  investors  who  purchase  stock in the  Company in a public
offering, to money managers or to securities analysts,  provided,  however, that
notwithstanding   anything  herein  to  the  contrary,   the  Company  will,  as
hereinabove  provided,  promptly notify the advisors and  representatives of the
Investors  and,  if any,  underwriters,  of any  event or the  existence  of any
circumstance   (without  any  obligation  to  disclose  the  specific  event  or
circumstance)  of which  it  becomes  aware,  constituting  material  non-public
information  (whether or not requested of the Company  specifically or generally
during the course of due diligence by such persons or entities),  which,  if not
disclosed in the prospectus  included in the Registration  Statement would cause
such  prospectus to include a material  misstatement  or to omit a material fact
required to be stated therein in order to make the statements,  therein in light
of the circumstances in which they were made, not misleading.  Nothing contained
in this  Section 8.2 shall be  construed  to mean that such  persons or entities
other than the Investors  (without the written  consent of an Investor  prior to
disclosure of such  information)  may not obtain  non-public  information in the
course  of  conducting  due  diligence  in  accordance  with  the  terms of this
Agreement  and nothing  herein shall  prevent any such persons or entities  from
notifying  the Company of their opinion that based on such due diligence by such
persons  or  entities,  that  the  Registration  Statement  contains  an  untrue
statement of a material  fact or omits a material  fact required to be stated in
the  Registration  Statement  or  necessary  to make  the  statements  contained
therein, in light of the circumstances in which they were made, not misleading.

                                   ARTICLE IX

                      Legends; Transfer Agent Instructions

Section  9.1.  Legends.   Unless  otherwise  provided  below,  each  certificate
representing Registrable Securities will bear the following legend or equivalent
(the "Legend"):

THE SECURITIES  EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
U.S.  SECURITIES ACT OF 1933, AS AMENDED (THE  "SECURITIES  ACT"),  OR ANY OTHER
APPLICABLE  SECURITIES  LAWS AND HAVE BEEN ISSUED IN RELIANCE  UPON AN EXEMPTION
FROM  THE  REGISTRATION  REQUIREMENTS  OF THE  SECURITIES  ACT  AND  SUCH  OTHER
SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION  HEREIN
MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, HYPOTHECATED
OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE  SECURITIES  ACT OR PURSUANT TO A TRANSACTION  THAT IS EXEMPT FROM, OR
NOT SUBJECT TO, SUCH REGISTRATION.


                                       16
<PAGE>


Section  9.2.  Transfer  Agent  Instructions.  Upon the  execution  and delivery
hereof,  the Company is issuing to the transfer  agent for its Common Stock (and
to any  substitute or  replacement  transfer agent for its Common Stock upon the
Company's  appointment  of any such  substitute or replacement  transfer  agent)
instructions in substantially  the form of Exhibit F hereto.  Such  instructions
shall be  irrevocable  by the Company from and after the date hereof or from and
after the issuance thereof to any such substitute or replacement transfer agent,
as the case may be.  It is the  intent  and  purpose  of such  instructions,  as
provided  therein,  to require the transfer agent for the Common Stock from time
to time  upon  transfer  of  Registrable  Securities  by the  Investor  to issue
certificates  evidencing such  Registrable  Securities free of the Legend during
the  following  periods  and  under  the  following  circumstances  and  without
consultation  by the transfer  agent with the Company or its counsel and without
the need for any further advice or instruction or  documentation to the transfer
agent by or from the  Company or its  counsel or the  Investor: 

     (a) at any time after the  Effective  Date,  upon  surrender of one or more
certificates  evidencing  Common  Stock  that  bear the  Legend,  to the  extent
accompanied by a notice  requesting the issuance of new certificates free of the
Legend  to  replace  those  surrendered;  provided  that  (i)  the  Registration
Statement  shall then be effective;  (ii) the Investor  confirms to the transfer
agent that it has sold,  pledged  or  otherwise  transferred  or agreed to sell,
pledge or otherwise  transfer such Common Stock in a bona fide  transaction to a
third party that is not an  affiliate  of the  Company;  and (iii) the  Investor
confirms  to the  transfer  agent  that  the  Investor  has  complied  with  the
prospectus delivery requirement.

     (b) at any time upon any surrender of one or more  certificates  evidencing
Registrable  Securities  that bear the Legend,  to the extent  accompanied  by a
notice requesting the issuance of new certificates free of the Legend to replace
those  surrendered  and  containing  representations  that (i) the  Investor  is
permitted to dispose of such  Registrable  Securities  without  limitation as to
amount or manner of sale  pursuant to Rule 144(k)  under the  Securities  Act or
(ii) the Investor has sold, pledged or otherwise  transferred or agreed to sell,
pledge or otherwise transfer such Registrable Securities in compliance with Rule
144.

Any of the  notices  referred  to  above  in  this  Section  9.2  may be sent by
facsimile to the Company's transfer agent.

Section 9.3. No Other  Legend or Stock  Transfer  Restrictions.  No legend other
than the one  specified  in Section 9.1 has been or shall be placed on the share
certificates  representing  the  Registrable  Securities and no  instructions or
"stop  transfer  orders,"  so called  "stock  transfer  restrictions,"  or other
restrictions  have been or shall be given to the Company's  transfer  agent with
respect thereto other than as expressly set forth in this Article IX.

Section 9.4. Investor's Compliance.  Nothing in this Article shall affect in any
way the Investors' obligations under any agreement to comply with all applicable
securities laws upon resale of the Common Stock.

                                   ARTICLE X

                                  Choice of Law

Section 10.1. Governing Law/Arbitration. This Agreement shall be governed by and
construed in  accordance  with the laws of the State of New York  applicable  to
contracts  made in New York by persons  domiciled  in New York City and  without
regard to its  principles of conflicts of laws. Any dispute under this Agreement
or any Exhibit  attached  hereto  shall be submitted  to  arbitration  under the
American  Arbitration  Association  (the "AAA") in New York City,  New York, and
shall be finally  and  conclusively  determined  by the  decision  of a board of
arbitration  consisting  of three (3)  members  (hereinafter  referred to as the
"Board of  Arbitration")  selected as according to the rules  governing the AAA.
The Board of Arbitration shall meet on


                                       17
<PAGE>


consecutive business days in New York City, New York, and shall reach and render
a decision in writing (concurred in by a majority of the members of the Board of
Arbitration)  with  respect to the  amount,  if any,  which the losing  party is
required to pay to the other party in respect of a claim  filed.  In  connection
with  rendering its decisions,  the Board of Arbitration  shall adopt and follow
the laws of the State of New York.  To the extent  practical,  decisions  of the
Board of  Arbitration  shall be rendered no more than thirty (30)  calendar days
following  commencement  of  proceedings  with  respect  thereto.  The  Board of
Arbitration  shall cause its written  decision  to be  delivered  to all parties
involved in the dispute.  Any decision made by the Board of Arbitration  (either
prior to or after the  expiration of such thirty (30) calendar day period) shall
be final,  binding and conclusive on the parties to the dispute, and entitled to
be enforced to the fullest  extent  permitted by law and entered in any court of
competent  jurisdiction.   The  non-prevailing  party  to  any  arbitration  (as
determined by the Board of Arbitration) shall pay the expenses of the prevailing
party including reasonable attorney's fees, in connection with such arbitration.

                                   ARTICLE XI

                          Assignment; Entire Agreement

Section 11.1. Assignment. Neither this Agreement nor any rights of the Investors
or the Company  hereunder  may be assigned by either party to any other  person.
Notwithstanding the foregoing,  (a) the provisions of this Agreement shall inure
to the benefit of, and be enforceable by, any permitted transferee of any of the
Convertible  Debenture  or  Warrants  purchased  or  acquired  by each  Investor
hereunder  with respect to the  Convertible  Debenture or Warrants  held by such
person,  and (b) upon the prior  written  consent of the Company,  which consent
shall not unreasonably be withheld or delayed,  each Investor's interest in this
Agreement  may be assigned at any time, in whole or in part, to any other person
or entity  (including  any  affiliate of such  Investor)  who agrees to make the
representations  and  warranties  contained  in Article III and who agrees to be
bound by the covenants of Article V.

                                  ARTICLE XII

                                     Notices

Section 12.1. Notices. All notices, demands, requests, consents,  approvals, and
other  communications  required or permitted  hereunder shall be in writing and,
unless  otherwise  specified  herein,  shall  be  (i)  personally  served,  (ii)
deposited  in the mail,  registered  or  certified,  return  receipt  requested,
postage  prepaid,  (iii) delivered by reputable air courier service with charges
prepaid, or (iv) transmitted by hand delivery, telegram, or facsimile, addressed
as set forth below or to such other  address as such party shall have  specified
most recently by written notice. Any notice or other  communication  required or
permitted to be given hereunder shall be deemed effective (a) upon hand delivery
or  delivery  by  facsimile,   with  accurate  confirmation   generated  by  the
transmitting  facsimile  machine,  at the address or number designated below (if
delivered on a business day during normal business hours where such notice is to
be received),  or the first  business day following  such delivery (if delivered
other than on a business day during normal  business  hours where such notice is
to be received) or (b) on the second  business day following the date of mailing
by reputable courier service, fully prepaid,  addressed to such address, or upon
actual receipt of such mailing,  whichever shall first occur.  The addresses for
such communications shall be:


                                       18
<PAGE>


If to the Company:                   IMSCO Technologies, Inc.
                                     40 Bayfield Drive
                                     North Andover, MA 01845
                                     Attention: Chief Executive Officer
                                     Telephone: (978) 689-2080
                                     Facsimile:  (978) 689-2585

with a copy to:                      Epstein Becker & Green, P.C.
(shall not constitute notice)        250 Park Avenue
                                     New York, NY 10177
                                     Attention: David E. Fleming, Esq.
                                     Telephone:  (212) 351-4500
                                     Facsimile:  (212)  661-0989
if to the Investor:
                                     as set forth on the signature page hereto.


with a copy to:
(shall not constitute notice)        Krieger & Prager
                                     319 Fifth Avenue
                                     3rd Floor
                                     New York, NY 10016
                                     Attention: Sam Krieger, Esq.
                                     Telephone: (212) 689-3322
                                     Facsimile: (212) 213-2077


Either party hereto may from time to time change its address or facsimile number
for notices  under this  Section 12.1 by giving  written  notice of such changed
address  or  facsimile  number to the other  party  hereto as  provided  in this
Section 12.1.

                                  ARTICLE XIII

                                  Miscellaneous

Section  13.1.  Counterparts/  Facsimile/  Amendments.  This  Agreement  may  be
executed  in multiple  counterparts,  each of which may be executed by less than
all of the parties and shall be deemed to be an original  instrument which shall
be enforceable  against the parties actually executing such counterparts and all
of which  together  shall  constitute  one and the same  instrument.  Except  as
otherwise  stated  herein,  in  lieu  of the  original  documents,  a  facsimile
transmission  or  copy of the  original  documents  shall  be as  effective  and
enforceable as the original.

This Agreement may be amended only by a writing executed by all parties. Section
13.2.  Entire  Agreement.  This Agreement,  the agreements  attached as Exhibits
hereto,  which include,  but are not limited to the Convertible  Debenture,  the
Warrant, the Escrow Agreement,  and the Registration Rights Agreement, set forth
the entire  agreement and  understanding  of the parties relating to the subject
matter  hereof  and  supersedes  all  prior  and   contemporaneous   agreements,
negotiations  and  understandings  between  the  parties,  both oral and written
relating to the subject matter hereof. The terms and


                                       19
<PAGE>


conditions  of all Exhibits to this  Agreement are  incorporated  herein by this
reference  and shall  constitute  part of this  Agreement  as is fully set forth
herein.

Section 13.3.  Severability.  In the event that any provision of this  Agreement
becomes or is  declared  by a court of  competent  jurisdiction  to be  illegal,
unenforceable  or void,  this Agreement  shall continue in full force and effect
without said provision;  provided that such severability shall be ineffective if
it materially changes the economic benefit of this Agreement to any party.

Section  13.4.  Headings.  The  headings  used in this  Agreement  are  used for
convenience only and are not to be considered in construing or interpreting this
Agreement.

Section 13.5. Reporting Entity for the Common Stock. The reporting entity relied
upon for the  determination of the trading price or trading volume of the Common
Stock on any given  Trading  Day for the  purposes  of this  Agreement  shall be
Bloomberg,  L.P. or any successor  thereto.  The written  mutual  consent of the
Investor and the Company shall be required to employ any other reporting entity.

Section  13.6.  Replacement  of  Certificates.  Upon  (i)  receipt  of  evidence
reasonably  satisfactory  to the  Company  of the loss,  theft,  destruction  or
mutilation  of a  certificate  representing  the  Convertible  Debenture  or any
Conversion  Shares or Warrant or any Warrant  Shares and (ii) in the case of any
such  loss,  theft or  destruction  of such  certificate,  upon  delivery  of an
indemnity  agreement or security  reasonably  satisfactory in form and amount to
the Company  (which  shall not exceed that  required by the  Company's  transfer
agent in the ordinary  course) or (iii) in the case of any such  mutilation,  on
surrender and cancellation of such certificate,  the Company at its expense will
execute and deliver, in lieu thereof, a new certificate of like tenor.

Section 13.7. Fees and Expenses. Each of the Company and the Investors agrees to
pay its own expenses incident to the performance of its obligations hereunder.

Section 13.8.  Brokerage.  Each of the parties hereto represents that it has had
no dealings in connection  with this  transaction  with any finder or broker who
will demand payment of any fee or commission  from the other party except Curzon
Management ("Curzon")who shall be paid by the Company a commission in the amount
of 10% of the Purchase Price ($60,000) and a  non-accountable  expense allowance
in the amount of 3% of the Purchase Price ($18,000). Curzon shall have the right
to  apply  the  commission  in the  amount  of  $60,000  to the  purchase  of an
additional  debenture  having  the same  terms,  conditions  and  rights  as the
Debenture.  The Company on the one hand,  and the  Investor,  on the other hand,
agree to indemnify  the other  against and hold the other  harmless from any and
all liabilities to any person claiming brokerage commissions or finder's fees on
account  of  services   purported  to  have  been  rendered  on  behalf  of  the
indemnifying  party  in  connection  with  this  Agreement  or the  transactions
contemplated hereby.



                                       20
<PAGE>


     IN WITNESS  WHEREOF,  the parties  hereto have caused this  Agreement to be
executed by the undersigned, thereunto duly authorized, as of the date first set
forth above.

                                               IMSCO TECHNOLOGIES, INC.



                                               By: /s/ Alexander T. Hoffmann
                                                  --------------------------
                                                   Alexander T. Hoffmann
                                                   Chief Executive Officer


                                               INVESTOR:

Address:                                       AMRO International, S.A.
c/o Ultra Finance
Grossmunster Platz 26
Zurich CH8022                                  By: /s/ H. U. Bachofen
Switzerland                                       -------------------------
                                                   H. U. Bachofen, Director

Facsimile: 011-411-262-5515


Amount subscribed for
              Debentures:  $600,000 principal amount
              Warrants:     120,000 shares
Total purchase price:      $601,200



                                       21


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission